胡文豪
职称：主任医师
科室：介入科
专业特长：擅长肝癌、肺癌等恶性肿瘤动脉化疗栓塞、消融、放射性粒子植入、靶向治疗等综合治疗，擅长子宫肌瘤、子宫腺肌症的介入治疗，擅长咯血等急重症介入诊疗。
教育经历：1987.9-1992.7温州医科大学医学临床专业本科； 2014.11-2017.12温州医科大学生物医学工程在职硕士学位。
学术任职：现任中国医师协会介入医师分会急诊介入专业委员会委员、中国抗癌协会肿瘤专业治疗委员会粒子治疗分会委员、中国抗癌协会肿瘤微创学会血管介入分会委员、浙江省医学会放射分会介入学组副主任、浙江省抗癌协会介入分会常委、温州医学会介入放射学分会副主任委员、中华消化病与影像杂志编委。
学术成果：近期发表文章： (1) Jian Zhang, Lili Zheng, Tian Zhao, Shiyong Huang, Wenhao Hu.A retrospective analysis of risk factors in recurrent hemoptysis patients with non-bronchial systematic artery feeding.Ann Transl Med 2020;8(23):1593 (2)JunLuo,JiapingZheng,ChangshengShi,JianFang,ZhiyiPeng,JingHuang,Wenhao Hu.Drug-eluting beads transarterial chemoembolization by Callispeheres is effective and well tolerated intreating intrahepatic cholangiocarinoma patients:a preliminary result from CTILC study.Mdicine(MD)(0025-7974),2020.4 （3）Hu,wenhao;Huang,Shiyong;zhangJian.MDR1 gene polymorphism correlated with pathological characteristics and prognosis in patients with primaiy hepatocellular carcinoma receiviing interventional therapy,Anti Cancer Drugs2019.30(3):233-240. （4）WH Hu, Z Hu, X Shen, LY Dong, XX Yu. C5a receptor enhances hepatocellular carcinoma cell invasiveness via activating ERK1/2-mediated epithelial–mesenchymal transition. Experimental & Molecular Pathology, 2016, 100(1): 101-108. （5）XX Yu
